A new study used genetic analysis to determine if copper or zinc levels could alter the risk of ischemic heart disease.
The results suggest that copper decreases disease risk, whereas zinc increases it.
Ischemic heart disease accounts for almost 13% of deaths worldwide, making it the single-largest cause of death in the world. Sometimes referred to as coronary artery disease, it is caused by the blockage of the coronary arteries of the heart.
As a consequence, the heart does not have enough oxygen to work properly. This can lead to chest pain, heart attacks, or long-term heart failure.
Some researchers believe that exposure to copper or zinc could affect ischemic heart disease. Unfortunately, it is difficult to experimentally confirm this in humans.
This is because most of the potential sources of copper or zinc exposure are strongly associated with socioeconomic status, and we already know that people with lower socioeconomic status are more likely to suffer from this disease.
This means that it would be difficult to differentiate between the effects of socioeconomic status and copper or zinc exposure.
A group of American researchers came up with a creative way to study this question. Instead of looking at dietary or environmental exposure, they identified genetic traits that were associated with higher or lower levels of these metals in the bloodstream.
They then investigated if people with these genetic traits were more or less likely to suffer from ischemic heart disease or have had a heart attack. They published the results of their study in The American Journal of Clinical Nutrition.
Two studies are better than one
Genome-wide association studies are used to find genetic variants that are associated with a trait of interest, such as susceptibility to disease.
These studies don’t sequence the entire genome, which is time-consuming and expensive. Instead, they specifically look at the parts of the genome that are known to vary from person to person.
For this study, the researchers took advantage of two separate genome-wide association studies that had already been done.
The first study identified genetic variants that were associated with zinc or copper concentration in the blood. This study looked at genetic variants in 2,603 people.
The second study identified genetic variants that were associated with ischemic heart disease or heart attacks. This study was much larger, including almost 300,000 people.
Copper may reduce the risk of ischemic heart disease and zinc may increase the risk
The first study showed that there were three parts of the human genome that seemed to be associated with changes in copper levels.
Another three parts of the human genome were associated with changes to zinc levels. These genetic variations only accounted for less than 10% of the person-to-person variation in the levels of these metals.
The researchers used the second study to tell if these genetic variants were associated with susceptibility to ischemic heart disease.
Despite the relatively small effect on metal levels, they found that these genetic variants were indeed associated with disease risk. People with genetic variants that increased copper levels were about 5% less likely to have ischemic heart disease.
In contrast, people with genetic variants that increased zinc levels were about 5% more likely to have ischemic heart disease.
The size of this effect may seem relatively small, but the researchers confirmed the effect by using several statistical tests. They were able to detect such small effects because of the large number of people that had been included in the genome-wide association studies.
More studies are needed
The researchers pointed out several shortcomings of their study.
First of all, it was a strictly observational study, so it couldn’t prove that changing copper or zinc levels actually affect ischemic heart disease. Furthermore, almost all of the people whose genomes were analyzed in this study were of European background.
It is therefore possible that these results may not apply to different ethnicities. Finally, it is possible that the genetic variants associated with metal levels are also associated with other biological factors.
It could be these other factors that actually affect disease risk.
Despite these shortcomings, this study strongly hints that copper and zinc levels may affect the risk of developing ischemic heart disease.
Copper supplementation could potentially decrease disease risk, but additional studies are needed to confirm that theory.
Written by Bryan Hughes, PhD
- Kodali, H. P., Pavilonis, B. T. & Schooling, C. M. Effects of copper and zinc on ischemic heart disease and myocardial infarction: a Mendelian randomization study. Am J Clin Nutr 108, 237-242 (2018)
- Finegold, J. A., Asaria, P. & Francis, D. P. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations. International Journal of Cardiology 168, 934-945 (2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819990/